Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uveal melanoma: In the era of new treatments
Mylène Wespiser, Ève-Marie Neidhardt, Sylvie Négrier
Cancer Treatment Reviews (2023) Vol. 119, pp. 102599-102599
Closed Access | Times Cited: 23

Showing 23 citing articles:

AIBI Modified Mesoporous Copper Sulfide Nanocomposites for Efficient Non‐Oxygen Dependent Free Radicals‐Assisted Photothermal Therapy in Uveal Melanoma
Pingping Huang, Lingdan Kong, Feiyu Zhang, et al.
Small (2024) Vol. 20, Iss. 27
Closed Access | Times Cited: 7
Self-modifying NanoEnhancers facilitating lysosomal escape for cGAS-STING cascading activation in tumor immunotherapy
Yanni Ge, Yuheng Bao, An Shao, et al.
Nano Today (2024) Vol. 57, pp. 102391-102391
Closed Access | Times Cited: 4
Unveiling the role of ACTL6A in uveal melanoma metastasis and immune microenvironment
Weiqin Liu, Qi Wan, Jin Lin, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113841-113841
Closed Access
Efficacy and safety of robotic Cyberknife radiotherapy in uveal melanoma: a systematic review and meta-analysis
Kun Du, Wenjuan Luo
Eye (2025)
Closed Access
Single-cell RNA sequencing and AlphaFold 3 insights into cytokine signaling and its role in uveal melanoma
Hongyan Sun, Cunzi Li, Zuhui Pu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Identification of new candidate genes for the hereditary predisposition to uveal melanoma: IGCMU trial
Mélanie Godiveau, Angeline Ginzac, Yannick Bidet, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Extracellular vesicles in uveal melanoma - biological roles and diagnostic value
Ornella Urzì, Roger Olofsson Bagge, Rossella Crescitelli
Cancer Letters (2025), pp. 217531-217531
Closed Access
Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma
Ahmed H. Al Sharie, S. Al-Omari, Abdelwahab Aleshawi, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
A Noninvasive Nanoeyedrop Therapy for the Inhibition of Uveal Melanoma: Tetrahedral Framework Nucleic Acid–Based Bioswitchable MicroRNA Delivery System
Jiang Zhou, Yichen Yang, Ziqi Yue, et al.
ACS Nano (2025)
Closed Access
Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis
Yating Dian, Yihuang Liu, Furong Zeng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances
Merve Kulbay, Nicolas Tuli, M. R. Mazza, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 108-108
Open Access
Direct Prediction of 48 Month Survival Status in Patients with Uveal Melanoma Using Deep Learning and Digital Cytopathology Images
T. Y. Alvin Liu, Haomin Chen, Neslihan Dilruba Köseoğlu, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 230-230
Open Access
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations
Liu Hon, Zhou Run‐hua, Jingxuan Pan, et al.
Pigment Cell & Melanoma Research (2024) Vol. 37, Iss. 3, pp. 411-425
Closed Access | Times Cited: 3
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications
Alessandra Loda, Francesco Semeraro, Silvia Parolini, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189104-189104
Open Access | Times Cited: 2
Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients
Minyao Zhao, Yue Yu, Zhengyu Song
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
STAT6/LINC01637 axis regulates tumor growth via autophagy and pharmacological targeting STAT6 as a novel strategy for uveal melanoma
Bo Liu, Xueting Yao, Qinying Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 1
Proton Therapy in Uveal Melanoma
Adrian Wai Chan, Haibo Lin, Irini Yacoub, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3497-3497
Open Access | Times Cited: 1
Long-term outcomes of ocular and visual preservation after carbon-ion radiotherapy for choroidal malignant melanoma.
Shuri Aoki, Masaru Wakatsuki, Hiroshi Tsuji, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Open Access
The BET inhibitor JQ1 suppresses tumor survival by ABCB5-mediated autophagy in uveal melanoma
Weiqin Liu, Zedu Cui, Qi Wan, et al.
Cellular Signalling (2024) Vol. 125, pp. 111483-111483
Closed Access
A novel EMT-related risk score model for Uveal melanoma based on ZNF667-AS1 and AP005121.1
Fan Yang, Yue Ren, Dongmei Qi, et al.
Journal of Cancer (2024) Vol. 16, Iss. 2, pp. 460-469
Closed Access
Unveiling the Role of ACTL6A in Uveal Melanoma Metastasis and Immune Microenvironment
Weiqin Liu, Qi Wan, Jin Lin, et al.
(2024)
Closed Access
Neutral Nanocomplex Delivers Plasmid Encoding α‐Hemolysin for Uveal Melanoma Treatment
Shanshan Wu, Liming He, Ling Yang, et al.
Advanced Therapeutics (2024)
Closed Access
UVEAL MELANOMA: A REVIEW
Silvio Tibo Cardoso Filho, Luan Mendes de Matos
International Journal of Health Science (2023) Vol. 4, Iss. 1, pp. 2-7
Open Access
Page 1

Scroll to top